RVNC - Revance Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - RVNC (1479290)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
23 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S5-1-0+8+49

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-07-06
RVNCAllouche CyrilPrincipal Financial OfficerS - Sale$28.35-3934,750-8%-$11,142
2018-05-22
RVNCSilvernail Lauren PCFO, CBOS - Sale$30.25-2,87465,497-4%-$86,924
2018-03-22
RVNCSilvernail Lauren PCFO, CBO, SecretaryS - Sale$30.85-3,43168,371-5%-$105,839
D
2018-03-16
RVNCGardner PhyllisDirS - Sale+OE$31.51-5,3333,000-64%-$168,045
2018-03-16
RVNCVickers Philip J.DirP - Purchase$31.24+3,1506,150+105%+$98,393
DM
2018-03-15
RVNCBrowne L DanielCEO, PresS - Sale+OE$31.64-6,452142,284-4%-$204,148
D
2018-03-13
RVNCSilvernail Lauren PCFO, CBO, SecretaryS - Sale+OE$34.50-25,86771,802-26%-$892,412
2018-03-07
RVNCBrowne L DanielCEO, PresS - Sale$31.43-27,283131,617-17%-$857,505
DM
2018-03-07
RVNCSilvernail Lauren PCFO, CBO, SecretaryS - Sale+OE$32.00-20,00072,954-22%-$640,000
2017-11-22
RVNCBrowne L DanielCEO, PresS - Sale$24.94-7,600133,597-5%-$189,570
2017-11-07
RVNCFoley Mark JDirP - Purchase$26.96+20,00026,000+333%+$539,168
D
2017-11-07
RVNCSilvernail Lauren PCFO, CBO, SecretaryS - Sale+OE$26.83-10,00049,006-17%-$268,267
2017-10-18
RVNCBrowne L DanielCEO, PresS - Sale$26.16-7,662141,197-5%-$200,405
2017-10-12
RVNCSilvernail Lauren PCFO, CBO, SecretaryS - Sale$26.67-11,16449,006-19%-$297,760
2017-09-20
RVNCBrowne L DanielCEO, PresS - Sale$23.58-7,600148,859-5%-$179,185
D
2017-08-23
RVNCBrowne L DanielCEO, PresS - Sale+OE$22.76-22,800156,459-13%-$519,031
2017-05-22
RVNCSilvernail Lauren PCFO, CBO, SecretaryS - Sale$20.20-1,79336,566-5%-$36,212
M
2017-05-22
RVNCBrowne L DanielCEO, PresS - Sale$20.29-32,000164,628-16%-$649,250
2017-02-22
RVNCBrowne L DanielCEO, PresS - Sale$20.57-11,037199,799-5%-$227,050+4-2-3
2017-01-25
RVNCBrowne L DanielCEO, PresS - Sale$19.78-12,000185,036-6%-$237,398-4+6+6
2016-12-28
RVNCBrowne L DanielCEO, PresS - Sale$20.94-12,000196,036-6%-$251,250+4+13-3
2016-11-25
RVNCBrowne L DanielCEO, PresS - Sale$17.92-12,000208,036-5%-$215,005-2-5+20
2016-10-26
RVNCBrowne L DanielCEO, PresS - Sale$14.85-12,000220,036-5%-$178,199-9-14+20+49
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top